New biomarkers identified for early detection of gynecological cancer

New biomarkers identified for early detection of gynecological cancer

Researchers from the University of Skövde, the University of Gothenburg, and the Sahlgrenska Academy have significantly advanced early detection of gynecological cancer.

Provider genetic testing may raise gynecological cancer testing rates

Offering genetic testing at the provider’s office at the time of diagnosis effectively increased the number of people with gynecological cancers who underwent testing. That’s according to a study at a single U.S. center that found that offering point-of-care genetic testing, administered at the doctor’s office or clinic, raised testing rates to 90% among these patients. Of those tested, more than 20% were found to carry disease-causing mutations…